Evidence map›Paper›PMID 34580741›Full record

ReviewWorld journal of microbiology & biotechnology2021

Prevalence and multidrug resistance in Salmonella enterica Typhimurium: an overview in South East Asia.

Saumya Darshana Patra, Nirmal Kumar Mohakud, Rakesh Kumar Panda, Bikash Ranjan Sahu, Mrutyunjay Suar

Abstract readReview
PubMed Publisher
In one paragraph

Review in World journal of microbiology & biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Factors InfluencingBiology · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Unlocking the potential ofFrontiers in microbiology · 2026
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Drug resistance and genotyping studies ofFrontiers in veterinary science · 2025
    Article
  13. Article
  14. Concomitant Therapy of InactivatedIndian journal of microbiology · 2024
    Article
  15. Assessing antimicrobial resistance profiles ofJournal of medical microbiology · 2024
    Article
  16. Article
  17. Persistence ofPathogens (Basel, Switzerland) · 2024
    Article
  18. TheVaccines · 2024
    Article
  19. Article
  20. Targeting lon protease to inhibit persister cell formation inFrontiers in cellular and infection microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Saumya Darshana PatraSchool of Biotechnology, KIIT University, Bhubaneswar, India.
Nirmal Kumar MohakudKalinga Institute of Medical Sciences, Bhubaneswar, India.
Rakesh Kumar PandaGovernment Medical College, Balangir, India.
Bikash Ranjan SahuSchool of Biotechnology, KIIT University, Bhubaneswar, India. bikashsahu74@yahoo.com.
Mrutyunjay SuarSchool of Biotechnology, KIIT University, Bhubaneswar, India. msuar@kiitbiotech.ac.in.ORCID http://orcid.org/0000-0002-2433-9100
KIIT University · INAll India Institute of Medical Sciences Bhubaneswar · INGovernment Medical College · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute/chronic gastroenteritis is caused by a few serovars of Salmonella enterica. Among different serovars, S. enterica Typhimurium is a potent pathogen that contributes significantly to self-limiting diarrhea related mortality worldwide. With no successful vaccine in hand against this pathogen, antibiotics are used as for gold standard for treatment against Salmonella induced gastroenteritis. Indispensably, rise in multi drug resistance against Salmonella Typhimurium poses challenge to treatment options. South East Asia, with 11 different countries, stands 3rd as super region for global burden of Salmonella induced gastroenteritis. In this review, we made an attempt to discuss on prevalence and multidrug resistance in Salmonella Typhimurium in 11 countries of South East Asia-the issue that has not been seriously addressed so far. By thorough analysis of reported data, we found varying frequencies for prevalence of Salmonella Typhimurium as well as subtle evidences on resistance of this pathogen to multiple antibiotics in different countries. Vietnam ranked top in terms of reports for prevalence and antimicrobial resistance. However, in countries such as Brunei and Timor Leste, no study has been performed so far to track the frequency of incidence and drug resistance of this pathogen. Our review, the first of its kind, emphasizes that, although the pathogen was not found as dominant serovar in South East Asia in last 20 years unlike sub-Saharan Africa, it may be still considered as a major threat in this region due to available evidences for infection in humans as well as contamination in several animal and food sources. More importantly, the importance as a public threat in this subregion of Asia is also due to resistance of this pathogen to multiple antibiotics. South East Asian countries showing incidence and multi drug resistance of Salmonella enterica Typhimurium in human and non-human sources (1969-2020). -Drug resistant S. enterica Typhimurium.

Indexed as

Drug Resistance, Multiple, BacterialAnimalsAnti-Bacterial AgentsAsia, EasternMicrobial Sensitivity TestsPrevalenceSalmonella entericaSalmonella InfectionsSalmonella typhimuriumSerogroupAnti-Bacterial AgentsMulti drug resistancePrevalenceSalmonella TyphimuriumSouth East Asia

Identifiers

PMID34580741
OpenAlexW3203076486

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.